Zacks Investment Research on MSN

AZN Wins FDA Nod for Expanded Use of Rare Disease Drug, Koselugo

AstraZeneca AZN announced that the FDA has approved its oral, selective MEK inhibitor, Koselugo (selumetinib), for expanded ...

For Kids, ADHD Pills Are Often Just the Start

This is an edition of the WSJ Health newsletter, a weekly briefing on what’s new in health, medicine, personal well-being and ...
Healio

On-demand sebetralstat generally safe in pediatric patients with hereditary angioedema

Among pediatric patients with hereditary angioedema, on-demand sebetralstat was generally safe and used within a median time of 30 minutes after attack onset, according to interim phase 3 trial ...